Ginkgo Bioworks Holdings (DNA)See remarks sold ~$5.4K
Mark E. Dmytruk, See remarks at Ginkgo Bioworks Holdings, sold ~$5.4K of Ginkgo Bioworks Holdings shares.
- ~$5.4K
- Approx. value · 706 sh @ $7.59
- 46K
- Holds after · shares reported
- Traded
- May 21, 2025
- Filed
- May 22, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Apr 21, 2025Insider · 2 peopleInsiders: 2 sales (~$16K)
- May 21, 2025 · this disclosureInsiderOfficer sold ~$5.4K of DNA shares in the open market
What came next
- May 21, 2025InsiderOfficer sold ~$2.6K of DNA shares in the open market
- Jul 17, 2025InsiderOfficer sold ~$11K of DNA shares in the open market
- Aug 22, 2025InsiderOfficer sold ~$3.8K of DNA shares in the open market
- Sep 8, 2025InsiderDirector sold ~$109K of DNA shares in the open market
- Sep 9, 2025InsiderDirector sold ~$111K of DNA shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Ginkgo Bioworks Holdings
For Ginkgo Bioworks Holdings, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 1 federal contract award dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DNA page.
Other recent filings by Mark E. Dmytruk, See remarks
- SEC Form 4 at Ginkgo Bioworks Holdings (DNA)Apr 23, 2025
- SEC Form 4 at Ginkgo Bioworks Holdings (DNA)Mar 6, 2025
- SEC Form 4 at Ginkgo Bioworks Holdings (DNA)Feb 6, 2025
- SEC Form 4 at Ginkgo Bioworks Holdings (DNA)Jan 8, 2025
- SEC Form 4 at Ginkgo Bioworks Holdings (DNA)Dec 5, 2024
The full history of Mark E. Dmytruk, See remarks is on the profile page.
How this filing works
Other disclosures at Ginkgo Bioworks Holdings
- SEC Form 4Oct 7, 2026
- SEC Form 144Oct 5, 2026
- USAspending.gov award recordAug 5, 2026
- SEC Form 13F-HRFeb 11, 2026
- SEC Form 13F-HRNov 12, 2025
- SEC Form 4Sep 10, 2025
Everything OQRO holds on this company is on its DNA page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
